Cargando…
A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ
Autism spectrum disorder (ASD) is often associated with debilitating sleep disturbances. While anecdotal evidence suggests the positive effect of cannabinoids, randomized studies are lacking. Here, we report the effects of cannabinoid treatment on the sleep of 150 children and adolescents with ASD,...
Autores principales: | Schnapp, Aviad, Harel, Moria, Cayam-Rand, Dalit, Cassuto, Hanoch, Polyansky, Lola, Aran, Adi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312464/ https://www.ncbi.nlm.nih.gov/pubmed/35884990 http://dx.doi.org/10.3390/biomedicines10071685 |
Ejemplares similares
-
Mediators of Placebo Response to Cannabinoid Treatment in Children with Autism Spectrum Disorder
por: Aran, Adi, et al.
Publicado: (2023) -
Cannabinoid treatment for autism: a proof-of-concept randomized trial
por: Aran, Adi, et al.
Publicado: (2021) -
Lower circulating endocannabinoid levels in children with autism spectrum disorder
por: Aran, Adi, et al.
Publicado: (2019) -
Medical Cannabis in Children
por: Aran, Adi, et al.
Publicado: (2020) -
Blood RNA Sequencing Indicates Upregulated BATF2 and LY6E and Downregulated ISG15 and MT2A Expression in Children with Autism Spectrum Disorder
por: Voinsky, Irena, et al.
Publicado: (2022)